220 related articles for article (PubMed ID: 18418364)
1. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.
Zhao Z; Baros AM; Zhang HT; Lapiz MD; Bondi CO; Morilak DA; O'Donnell JM
Neuropsychopharmacology; 2008 Dec; 33(13):3190-200. PubMed ID: 18418364
[TBL] [Abstract][Full Text] [Related]
2. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
[TBL] [Abstract][Full Text] [Related]
3. Enduring attenuation of norepinephrine synaptic availability and augmentation of the pharmacological and behavioral effects of desipramine by repeated immobilization stress.
Gonzáles MA; Miranda AP; Orrego H; Silva R; Forray MI
Neuropharmacology; 2017 May; 117():249-259. PubMed ID: 28232061
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of norepinephrine transporter expression on membrane surface induced by chronic administration of desipramine and the antagonism by co-administration of local anesthetics in mice.
Song L; Kitayama T; Morita K; Morioka N; Dohi T
Neurochem Int; 2008; 52(4-5):826-33. PubMed ID: 17981365
[TBL] [Abstract][Full Text] [Related]
5. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
6. Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression.
Jeannotte AM; McCarthy JG; Redei EE; Sidhu A
Neuropsychopharmacology; 2009 Mar; 34(4):987-98. PubMed ID: 18800064
[TBL] [Abstract][Full Text] [Related]
7. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
Reynolds JL; Ignatowski TA; Sud R; Spengler RN
Neuroscience; 2005; 133(2):519-31. PubMed ID: 15878644
[TBL] [Abstract][Full Text] [Related]
8. Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.
Erickson SL; Gandhi AR; Asafu-Adjei JK; Sampson AR; Miner L; Blakely RD; Sesack SR
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1219-32. PubMed ID: 21208501
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.
Mitchell NC; Bowman MA; Gould GG; Koek W; Daws LC
J Pharmacol Exp Ther; 2017 Jan; 360(1):84-94. PubMed ID: 27831486
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
Kiyono Y; Sugita T; Ueda M; Kawashima H; Kanegawa N; Kuge Y; Fujibayashi Y; Saji H
Nucl Med Biol; 2008 Feb; 35(2):213-8. PubMed ID: 18312831
[TBL] [Abstract][Full Text] [Related]
11. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.
Hill MN; Ho WS; Sinopoli KJ; Viau V; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2006 Dec; 31(12):2591-9. PubMed ID: 16710317
[TBL] [Abstract][Full Text] [Related]
13. Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.
Zavosh A; Schaefer J; Ferrel A; Figlewicz DP
Brain Res Bull; 1999 Jul; 49(4):291-5. PubMed ID: 10424850
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.
Hoshaw BA; Hill TI; Crowley JJ; Malberg JE; Khawaja X; Rosenzweig-Lipson S; Schechter LE; Lucki I
Eur J Pharmacol; 2008 Oct; 594(1-3):109-16. PubMed ID: 18675266
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo.
Heidbreder CA; Bianchi M; Lacroix LP; Faedo S; Perdona E; Remelli R; Cavanni P; Crespi F
Synapse; 2003 Dec; 50(4):269-76. PubMed ID: 14556231
[TBL] [Abstract][Full Text] [Related]
16. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test.
Espejo EF; Miñano FJ
Neuroscience; 1999 Jan; 88(2):609-15. PubMed ID: 10197779
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
García-Fuster MJ; García-Sevilla JA
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2955-71. PubMed ID: 27259485
[TBL] [Abstract][Full Text] [Related]
18. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
[TBL] [Abstract][Full Text] [Related]
19. Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum.
Jeannotte AM; McCarthy JG; Sidhu A
Neurosci Lett; 2009 Dec; 467(2):86-9. PubMed ID: 19818834
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats.
Tejani-Butt SM; Paré WP; Yang J
Brain Res; 1994 Jun; 649(1-2):27-35. PubMed ID: 7953642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
